Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: Efficacy and cost analysis study

S. Afifi, N. G. Adel, S. Devlin, E. Duck, J. Vanak, H. Landau, D. J. Chung, N. Lendvai, A. Lesokhin, N. Korde, L. Reich, O. Landgren, S. Giralt, H. Hassoun

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: Efficacy and cost analysis study'. Together they form a unique fingerprint.

Medicine & Life Sciences